# PayPal Holdings, Inc.: financial statements, quarterly

PYPL · Nasdaq · CIK 1633917 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pypl.md) · [Financials](/companies/pypl/financials.md) · [Filings](/companies/pypl/filings.md) · [Insiders](/companies/pypl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pypl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [8,026 d](/filings/0001633917-26-000024.md) | [7,699](/filings/0001633917-25-000064.md) | [7,885](/filings/0001633917-25-000161.md) | [7,847](/filings/0001633917-25-000196.md) | [8,366 d](/filings/0001633917-26-000024.md) | [7,791](/filings/0001633917-26-000067.md) | [8,288](/filings/0001633917-26-000082.md) | [8,417](/filings/0001633917-26-000088.md) | [8,676 d](/filings/0001633917-26-000024.md) | [8,353](/filings/0001633917-26-000067.md) | [8,682](/filings/0001633917-26-000082.md) | [8,584](/filings/0001633917-26-000088.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [1,728 d](/filings/0001633917-26-000024.md) | [1,168](/filings/0001633917-25-000064.md) | [1,325](/filings/0001633917-25-000161.md) | [1,391](/filings/0001633917-25-000196.md) | [1,441 d](/filings/0001633917-26-000024.md) | [1,530](/filings/0001633917-26-000067.md) | [1,504](/filings/0001633917-26-000082.md) | [1,520](/filings/0001633917-26-000088.md) | [1,511 d](/filings/0001633917-26-000024.md) | [1,488](/filings/0001633917-26-000067.md) | [1,427](/filings/0001633917-26-000082.md) | [1,402](/filings/0001633917-26-000088.md) |
| Interest expense | $m | [87.0 d](/filings/0001633917-24-000024.md) | [86.0](/filings/0001633917-24-000048.md) | [93.0](/filings/0001633917-25-000161.md) | [106](/filings/0001633917-25-000196.md) | [97.0 d](/filings/0001633917-26-000024.md) | [103](/filings/0001633917-26-000067.md) | [114](/filings/0001633917-26-000082.md) | [113](/filings/0001633917-26-000088.md) | [111 d](/filings/0001633917-26-000024.md) | [111](/filings/0001633917-26-000067.md) | [126](/filings/0001633917-26-000082.md) | [138](/filings/0001633917-26-000088.md) |
| Income tax | $m | [391 d](/filings/0001633917-26-000024.md) | [321](/filings/0001633917-25-000064.md) | [271](/filings/0001633917-25-000161.md) | [301](/filings/0001633917-25-000196.md) | [289 d](/filings/0001633917-26-000024.md) | [316](/filings/0001633917-26-000067.md) | [268](/filings/0001633917-26-000082.md) | [285](/filings/0001633917-26-000088.md) | [190 d](/filings/0001633917-26-000024.md) | [280](/filings/0001633917-26-000067.md) | [206](/filings/0001633917-26-000082.md) | [301](/filings/0001633917-26-000088.md) |
| Net income | $m | [1,402 d](/filings/0001633917-26-000024.md) | [888](/filings/0001633917-25-000196.md) | [1,128](/filings/0001633917-25-000196.md) | [1,010](/filings/0001633917-25-000196.md) | [1,121 d](/filings/0001633917-26-000024.md) | [1,287](/filings/0001633917-26-000088.md) | [1,261](/filings/0001633917-26-000088.md) | [1,248](/filings/0001633917-26-000088.md) | [1,437 d](/filings/0001633917-26-000024.md) | [1,113](/filings/0001633917-26-000088.md) | [1,104](/filings/0001633917-26-000088.md) | [1,073](/filings/0001633917-26-000088.md) |
| Diluted EPS | $ per share | not reported | [0.83](/filings/0001633917-25-000064.md) | [1.08](/filings/0001633917-25-000161.md) | [0.99](/filings/0001633917-25-000196.md) | not reported | [1.29](/filings/0001633917-26-000067.md) | [1.29](/filings/0001633917-26-000082.md) | [1.30](/filings/0001633917-26-000088.md) | not reported | [1.21](/filings/0001633917-26-000067.md) | [1.25](/filings/0001633917-26-000082.md) | [1.25](/filings/0001633917-26-000088.md) |
| Basic EPS | $ per share | not reported | [0.83](/filings/0001633917-25-000064.md) | [1.08](/filings/0001633917-25-000161.md) | [1.00](/filings/0001633917-25-000196.md) | not reported | [1.31](/filings/0001633917-26-000067.md) | [1.30](/filings/0001633917-26-000082.md) | [1.31](/filings/0001633917-26-000088.md) | not reported | [1.22](/filings/0001633917-26-000067.md) | [1.26](/filings/0001633917-26-000082.md) | [1.26](/filings/0001633917-26-000088.md) |

- Revenue: us-gaap:Revenues
- Research and development: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [9.1](/filings/0001633917-26-000024.md) | [9.7](/filings/0001633917-25-000064.md) | [7.8](/filings/0001633917-25-000161.md) | [7.4](/filings/0001633917-25-000196.md) | [6.7](/filings/0001633917-26-000024.md) | [7.6](/filings/0001633917-26-000067.md) | [6.7](/filings/0001633917-26-000082.md) | [9.0](/filings/0001633917-26-000088.md) | [8.0](/filings/0001633917-26-000088.md) | [7.0](/filings/0001633917-26-000067.md) | [8.3](/filings/0001633917-26-000082.md) | [7.2](/filings/0001633917-26-000088.md) |
| Current assets | $bn | [62.6](/filings/0001633917-25-000019.md) | [63.7](/filings/0001633917-24-000048.md) | [63.0](/filings/0001633917-24-000098.md) | [62.7](/filings/0001633917-24-000110.md) | [58.2](/filings/0001633917-26-000024.md) | [60.6](/filings/0001633917-25-000064.md) | [59.9](/filings/0001633917-25-000161.md) | [60.2](/filings/0001633917-25-000196.md) | [59.8](/filings/0001633917-26-000088.md) | [60.0](/filings/0001633917-26-000067.md) | [62.3](/filings/0001633917-26-000082.md) | [60.5](/filings/0001633917-26-000088.md) |
| Total assets | $bn | [82.2](/filings/0001633917-25-000019.md) | [83.3](/filings/0001633917-24-000048.md) | [84.0](/filings/0001633917-24-000098.md) | [83.5](/filings/0001633917-24-000110.md) | [78.7](/filings/0001633917-26-000024.md) | [81.3](/filings/0001633917-25-000064.md) | [79.8](/filings/0001633917-25-000161.md) | [79.8](/filings/0001633917-25-000196.md) | [80.2](/filings/0001633917-26-000088.md) | [80.5](/filings/0001633917-26-000067.md) | [82.7](/filings/0001633917-26-000082.md) | [81.6](/filings/0001633917-26-000088.md) |
| Current liabilities | $bn | [48.5](/filings/0001633917-25-000019.md) | [49.8](/filings/0001633917-24-000048.md) | [50.7](/filings/0001633917-24-000098.md) | [50.3](/filings/0001633917-24-000110.md) | [45.5](/filings/0001633917-26-000024.md) | [46.6](/filings/0001633917-25-000064.md) | [45.1](/filings/0001633917-25-000161.md) | [44.9](/filings/0001633917-25-000196.md) | [46.4](/filings/0001633917-26-000088.md) | [47.6](/filings/0001633917-26-000067.md) | [48.4](/filings/0001633917-26-000082.md) | [47.9](/filings/0001633917-26-000088.md) |
| Total liabilities | $bn | [61.1](/filings/0001633917-25-000019.md) | [62.6](/filings/0001633917-24-000048.md) | [63.4](/filings/0001633917-24-000098.md) | [63.3](/filings/0001633917-24-000110.md) | [58.3](/filings/0001633917-26-000024.md) | [61.0](/filings/0001633917-25-000064.md) | [59.6](/filings/0001633917-25-000161.md) | [59.6](/filings/0001633917-25-000196.md) | [59.9](/filings/0001633917-26-000088.md) | [60.5](/filings/0001633917-26-000067.md) | [62.9](/filings/0001633917-26-000082.md) | [62.1](/filings/0001633917-26-000088.md) |
| Long-term debt | $bn | [9.7](/filings/0001633917-25-000019.md) | [9.7](/filings/0001633917-24-000048.md) | [9.7](/filings/0001633917-24-000098.md) | [10.0](/filings/0001633917-24-000110.md) | [9.9](/filings/0001633917-26-000024.md) | [11.4](/filings/0001633917-25-000064.md) | [11.3](/filings/0001633917-25-000161.md) | [11.3](/filings/0001633917-25-000196.md) | [10.0](/filings/0001633917-26-000088.md) | [9.4](/filings/0001633917-26-000067.md) | [10.9](/filings/0001633917-26-000082.md) | [10.9](/filings/0001633917-26-000088.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [1.4](/filings/0001633917-26-000088.md) | not reported | [2.5](/filings/0001633917-26-000082.md) | [2.3](/filings/0001633917-26-000088.md) |
| Shareholders' equity | $bn | [21.1](/filings/0001633917-26-000024.md) | [20.7](/filings/0001633917-25-000196.md) | [20.6](/filings/0001633917-25-000196.md) | [20.2](/filings/0001633917-25-000196.md) | [20.4](/filings/0001633917-26-000088.md) | [20.3](/filings/0001633917-26-000088.md) | [20.2](/filings/0001633917-26-000088.md) | [20.2](/filings/0001633917-26-000088.md) | [20.3](/filings/0001633917-26-000088.md) | [20.0](/filings/0001633917-26-000088.md) | [19.8](/filings/0001633917-26-000088.md) | [19.5](/filings/0001633917-26-000088.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent, us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2,614 d](/filings/0001633917-26-000024.md) | [1,917](/filings/0001633917-25-000064.md) | [1,525 d](/filings/0001633917-25-000161.md) | [1,614 d](/filings/0001633917-25-000196.md) | [2,394 d](/filings/0001633917-26-000024.md) | [1,160](/filings/0001633917-26-000067.md) | [898 d](/filings/0001633917-26-000082.md) | [1,974 d](/filings/0001633917-26-000088.md) | [2,384 d](/filings/0001633917-26-000024.md) | [1,134](/filings/0001633917-26-000067.md) | [1,983 d](/filings/0001633917-26-000082.md) | [1,592 d](/filings/0001633917-26-000088.md) |
| Capital expenditure | $m | [145 d](/filings/0001633917-26-000024.md) | [154](/filings/0001633917-25-000064.md) | [157 d](/filings/0001633917-25-000161.md) | [169 d](/filings/0001633917-25-000196.md) | [203 d](/filings/0001633917-26-000024.md) | [196](/filings/0001633917-26-000067.md) | [206 d](/filings/0001633917-26-000082.md) | [256 d](/filings/0001633917-26-000088.md) | [194 d](/filings/0001633917-26-000024.md) | [231](/filings/0001633917-26-000067.md) | [208 d](/filings/0001633917-26-000082.md) | [161 d](/filings/0001633917-26-000088.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001633917-26-000067.md) | [0.0 d](/filings/0001633917-26-000082.md) | [0.0 d](/filings/0001633917-26-000088.md) | [130 d](/filings/0001633917-26-000024.md) | [130](/filings/0001633917-26-000067.md) | [122 d](/filings/0001633917-26-000082.md) | [118 d](/filings/0001633917-26-000088.md) |
| Share repurchases | $m | [607 d](/filings/0001633917-26-000024.md) | [1,501](/filings/0001633917-25-000064.md) | [1,501 d](/filings/0001633917-25-000161.md) | [1,776 d](/filings/0001633917-25-000196.md) | [1,269 d](/filings/0001633917-26-000024.md) | [1,500](/filings/0001633917-26-000067.md) | [1,551 d](/filings/0001633917-26-000082.md) | [1,500 d](/filings/0001633917-26-000088.md) | [1,501 d](/filings/0001633917-26-000024.md) | [1,500](/filings/0001633917-26-000067.md) | [1,552 d](/filings/0001633917-26-000082.md) | [1,501 d](/filings/0001633917-26-000088.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,134](/filings/0001633917-24-000048.md) | [1,114](/filings/0001633917-24-000098.md) | [1,098](/filings/0001633917-24-000110.md) | [1,072](/filings/0001633917-25-000064.md) | [1,047](/filings/0001633917-25-000161.md) | [1,024](/filings/0001633917-25-000196.md) | [999](/filings/0001633917-26-000067.md) | [977](/filings/0001633917-26-000082.md) | [960](/filings/0001633917-26-000088.md) | [920](/filings/0001633917-26-000067.md) | [882](/filings/0001633917-26-000082.md) | [858](/filings/0001633917-26-000088.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 830,658,298 at 2026-10-21, from the cover of the [10-Q filed 2026-10-27](/filings/0001633917-26-000088.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 27, 2026, 22:08 ET. No prices; not investment advice.